Case Report

Published: Oct 18, 2026 | DOI: 10.24911/ejmcr.9-2952

Longitudinally extensive transverse myelitis as the first manifestation of probable neurosarcoidosis - case report


Authors: Paula Olszewska , Maciej Olszewski , Oskar Bozek , Lukasz Mazurek , Tomasz Paleczny , Krzysztof Wierzbicki ,


Abstract

Background: Sarcoidosis, as a rare disease, affects 0.01% of the population; involvement of the central nervous system is even less common.

Case presentation: A 46-year-old man suffering from ulcerative colitis and epilepsy was hospitalized in the neurology department due to progressive, ascending paresthesia and quadriplegia accompanied by sphincter and balance disorders. Magnetic resonance imaging revealed extensive edematous changes extending from the medulla oblongata to the Th7 level and multiple enlarged mediastinal lymph nodes. Diagnostic workup was expanded to include a contrast-enhanced computed tomography scan of the chest, which revealed numerous enlarged lymph nodes in the mediastinum and scattered small nodular lesions in the lung parenchyma. After performing a histopathological examination of the subcarinal lymph node biopsy material, a diagnosis of sarcoidosis was made. The patient was diagnosed with longitudinal extensive transverse myelitis (LETM) in the course of probable neurosarcoidosis and was treated showed clinical improvement following treatment.

Conclusion: Although central nervous system involvement is not a common manifestation of this disease, immediate medical attention is necessary if it occurs. The management of patients with neurosarcoidosis requires a multidisciplinary approach, that improves the patient’s chances of achieving long-term remission.

 


Keywords: Case report, LETM, neurosarcoidosis, sarcoidosis, ulcerative colitis.



Pubmed Style

Paula Olszewska, Maciej Olszewski, Oskar Bozek, Lukasz Mazurek, Tomasz Paleczny, Krzysztof Wierzbicki. Longitudinally extensive transverse myelitis as the first manifestation of probable neurosarcoidosis - case report. EJMCR. 2026; 18 (October 2026): -. doi:10.24911/ejmcr.9-2952

Publication History

Received: June 11, 2026

Revised: September 09, 2026 Revised: September 13, 2026 Revised: September 18, 2026

Accepted: September 25, 2026

Published: October 18, 2026


Authors

Paula Olszewska

Department of Allergology and Clinical Immunology, Medical University of Silesia, Katowice, Poland.

Maciej Olszewski

Department of Neurology, Silesian Hospital in Cieszyn, Cieszyn, Poland.

Oskar Bozek

Department of Radiology and Nuclear Medicine, Faculty of Medical Sciences in Katowice, Medical University of Silesia, Katowice, Poland.

Lukasz Mazurek

Tomograf Sp. z o.o. Independent Diagnostic Imaging Unit.

Tomasz Paleczny

Diagnostic Imaging Department, Silesian Hospital in Cieszyn, Cieszyn, Poland.

Krzysztof Wierzbicki

Department of Neurology, Silesian Hospital in Cieszyn, Cieszyn, Poland.